{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:36:51Z","timestamp":1792737411516,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,7]],"date-time":"2012-01-07T00:00:00Z","timestamp":1325894400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Obstet Gynecol Rep"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s13669-011-0004-1","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T18:13:34Z","timestamp":1325873614000},"page":"1-9","source":"Crossref","is-referenced-by-count":93,"title":["Ovarian Cancer is an Imported Disease: Fact or Fiction?"],"prefix":"10.1007","volume":"1","author":[{"given":"Elisabetta","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Kurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,7]]},"reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","volume":"305","author":"SS Buys","year":"2011","unstructured":"\u2022 Buys SS, Partridge E, Black A, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 2011;305:2295\u20132303. This population-based study analyzed the PLCO cases in an attempt to determine whether CA125 and an imaging study can save the lives of ovarian cancer patients. The study result provides cogent evidence of a lack of effective screening to reduce ovarian cancer deaths.","journal-title":"JAMA"},{"key":"4_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ajog.2005.01.041","volume":"192","author":"DA Fishman","year":"2005","unstructured":"Fishman DA, Cohen L, Blank SV, et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol. 2005;192:1214\u201321. discussion 1221\u20131212.","journal-title":"Am J Obstet Gynecol"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","volume":"198","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Visvanathan K, Roden R, et al. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol. 2008;198:351\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/978-1-4419-0489-8_14","volume-title":"Blaustein\u2019s Pathology of the Female Genital Tract","author":"JD Seidman","year":"2011","unstructured":"Seidman JD, Cho K, Ronnett BM, et al. Surface epithelial tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein\u2019s Pathology of the Female Genital Tract. New York: Springer Verlag; 2011. p. 679\u2013784."},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"IM Shih","year":"2004","unstructured":"Shih IM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511\u20138.","journal-title":"Am J Pathol"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1196333","volume":"330","author":"S Jones","year":"2010","unstructured":"Jones S, Wang TL, Shih IM, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science. 2010;330:228\u201331.","journal-title":"Science"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"KC Wiegand","year":"2010","unstructured":"Wiegand KC, Shah SP, Al-Agha OM, et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363:1532\u201343.","journal-title":"N Engl J Med"},{"key":"4_CR9","doi-asserted-by":"crossref","unstructured":"Jones S, Wang TL, Kurman RJ, et al. Low-grade serous carcinomas of the ovary contain very few point mutations. J Pathol 2011 Nov 21 (Epub ahead of print).","DOI":"10.1002\/path.3967"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315.","journal-title":"Nature"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/1078-0432.CCR-09-2105","volume":"16","author":"K Kuo","year":"2010","unstructured":"Kuo K, Mao T, Feng Y, et al. DNA copy number profiles in affinity-purified ovarian clear cell carcinoma. Clin Cancer Res. 2010;16:1997\u20132008.","journal-title":"Clin Cancer Res"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/0008-5472.CAN-08-3913","volume":"69","author":"KT Kuo","year":"2009","unstructured":"Kuo KT, Guan B, Feng Y, et al. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. Cancer Res. 2009;69:4036\u201342.","journal-title":"Cancer Res"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","volume":"30","author":"N Auersperg","year":"2011","unstructured":"Auersperg N. The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol. 2011;30:12\u201321.","journal-title":"Int J Gynecol Pathol"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1470-2045(06)70983-4","volume":"8","author":"JR McLaughlin","year":"2007","unstructured":"McLaughlin JR, Risch HA, Lubinski J, et al. Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case\u2013control study. Lancet Oncol. 2007;8:26\u201334.","journal-title":"Lancet Oncol"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF. Incessant ovulation\u2013a factor in ovarian neoplasia? Lancet. 1971;2:163.","journal-title":"Lancet"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.22.2.255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, et al. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001;22:255\u201388.","journal-title":"Endocr Rev"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/gyno.1998.5275","volume":"72","author":"L Dubeau","year":"1999","unstructured":"Dubeau L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: Does the emperor have no clothes? Gynecol Oncol. 1999;72:437\u201342.","journal-title":"Gynecol Oncol"},{"key":"4_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.03.023","volume":"114","author":"KQ Cai","year":"2009","unstructured":"Cai KQ, Wu H, Klein-Szanto AJ, et al. Acquisition of a second mutation of the Tp53 alleles immediately precedes epithelial morphological transformation in ovarian tumorigenicity. Gynecol Oncol. 2009;114:18\u201325.","journal-title":"Gynecol Oncol"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1525-1438.1997.00379.x","volume":"7","author":"L Deligdisch","year":"1997","unstructured":"Deligdisch L. Ovarian dysplasia: a review. Int J Gynecol Cancer. 1997;7:89\u201394.","journal-title":"Int J Gynecol Cancer"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I","volume":"86","author":"L Deligdisch","year":"1999","unstructured":"Deligdisch L, Gil J, Kerner H, et al. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Cancer. 1999;86:1544\u201350.","journal-title":"Cancer"},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/cncr.10497","volume":"94","author":"DH Yang","year":"2002","unstructured":"Yang DH, Smith ER, Cohen C, et al. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer. 2002;94:2380\u201392.","journal-title":"Cancer"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP, et al. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol. 2001;195:451\u20136.","journal-title":"J Pathol"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","volume":"34","author":"CG Przybycin","year":"2010","unstructured":"\u2022 Przybycin CG, Kurman RJ, Ronnett BM, et al. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 2010;34:1407\u20131416. This study was based on a relatively large retrospective cohort to demonstrate the percentage of ovarian cancer that is associated with serous tubal intraepithelial carcinoma. The results provide evidence that most so-called ovarian cancers are associated with concurrent serous tubal intraepithelial carcinoma.","journal-title":"Am J Surg Pathol"},{"key":"4_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","volume":"100","author":"A Finch","year":"2006","unstructured":"Finch A, Shaw P, Rosen B, et al. Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. Gynecol Oncol. 2006;100:58\u201364.","journal-title":"Gynecol Oncol"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","volume":"25","author":"MJ Callahan","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F, et al. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol. 2007;25:3985\u201390.","journal-title":"J Clin Oncol"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","volume":"31","author":"DW Kindelberger","year":"2007","unstructured":"Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 2007;31:161\u20139.","journal-title":"Am J Surg Pathol"},{"key":"4_CR27","doi-asserted-by":"crossref","unstructured":"\u2022 Kuhn E, Kurman RJ, Vang R, et al. TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions. J Pathol 2011 Oct 12. doi: 10.1002\/path.3023 . This recent study shows the mutational profiles of TP53 in high-grade ovarian serous carcinoma and concurrent serous tubal intraepithelial carcinoma. The results from this report demonstrate that both lesions share identical TP53 mutations, suggesting their clonal relationship and supporting the idea that serous tubal intraepithelial carcinoma may be the precursor of high-grade ovarian serous carcinoma.","DOI":"10.1002\/path.3023"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1158\/1078-0432.CCR-04-2509","volume":"11","author":"RT Marquez","year":"2005","unstructured":"Marquez RT, Baggerly KA, Patterson AP, et al. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res. 2005;11:6116\u201326.","journal-title":"Clin Cancer Res"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","volume":"23","author":"AS Sehdev","year":"2010","unstructured":"Sehdev AS, Kurman RJ, Kuhn E, et al. Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase. Mod Pathol. 2010;23:844\u201355.","journal-title":"Mod Pathol"},{"key":"4_CR30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","volume":"34","author":"E Kuhn","year":"2010","unstructured":"Kuhn E, Meeker A, Wang TL, et al. Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis. Am J Surg Pathol. 2010;34:829\u201336.","journal-title":"Am J Surg Pathol"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","volume":"247","author":"JS Fleming","year":"2006","unstructured":"Fleming JS, Beaugie CR, Haviv I, et al. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol. 2006;247:4\u201321.","journal-title":"Mol Cell Endocrinol"},{"key":"4_CR32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.10927","volume":"104","author":"DM Purdie","year":"2003","unstructured":"Purdie DM, Bain CJ, Siskind V, et al. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104:228\u201332.","journal-title":"Int J Cancer"},{"key":"4_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.cej.0000179274.24200.9d","volume":"15","author":"C Vecchia La","year":"2006","unstructured":"La Vecchia C. Oral contraceptives and ovarian cancer: an update, 1998\u20132004. Eur J Cancer Prev. 2006;15:117\u201324.","journal-title":"Eur J Cancer Prev"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0968-0004(02)02110-2","volume":"27","author":"T Zglinicki von","year":"2002","unstructured":"von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339\u201344.","journal-title":"Trends Biochem Sci"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/153537020422900613","volume":"229","author":"WJ Murdoch","year":"2004","unstructured":"Murdoch WJ, Martinchick JF. Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: carcinogenic implication and chemoprevention. Exp Biol Med (Maywood). 2004;229:546\u201352.","journal-title":"Exp Biol Med (Maywood)"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1095\/biolreprod.105.042622","volume":"73","author":"WJ Murdoch","year":"2005","unstructured":"Murdoch WJ. Carcinogenic potential of ovulatory genotoxicity. Biol Reprod. 2005;73:586\u201390.","journal-title":"Biol Reprod"},{"key":"4_CR37","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1158\/0008-5472.CAN-04-2067","volume":"64","author":"CL Ho","year":"2004","unstructured":"Ho CL, Kurman RJ, Dehari R, et al. Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors. Cancer Res. 2004;64:6915\u20138.","journal-title":"Cancer Res"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e318229449f","volume":"35","author":"RJ Kurman","year":"2011","unstructured":"Kurman RJ, Vang R, Junge J, et al. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. Am J Surg Pathol. 2011;35:1605\u201314.","journal-title":"Am J Surg Pathol"},{"key":"4_CR39","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1158\/1078-0432.CCR-05-0755","volume":"11","author":"IM Shih","year":"2005","unstructured":"Shih IM, Kurman RJ. Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res. 2005;11:7273\u20139.","journal-title":"Clin Cancer Res"},{"key":"4_CR40","first-page":"93","volume":"3","author":"JA Sampson","year":"1927","unstructured":"Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol. 1927;3:93\u2013110.43.","journal-title":"Am J Pathol"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/PAS.0b013e31819c4271","volume":"33","author":"E Veras","year":"2009","unstructured":"Veras E, Mao TL, Ayhan A, et al. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol. 2009;33:844\u201353.","journal-title":"Am J Surg Pathol"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2559.1997.d01-592.x","volume":"30","author":"M Fukunaga","year":"1997","unstructured":"Fukunaga M, Nomura K, Ishikawa E, et al. Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology. 1997;30:249\u201355.","journal-title":"Histopathology"},{"key":"4_CR43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/00313027909063533","volume":"11","author":"P Russell","year":"1979","unstructured":"Russell P. The pathological assessment of ovarian neoplasms. I: Introduction to the common \u2018epithelial\u2019 tumours and analysis of benign \u2018epithelial\u2019 tumours. Pathology. 1979;11:5\u201326.","journal-title":"Pathology"},{"key":"4_CR44","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00404-011-2047-y","volume":"284","author":"A Kokcu","year":"2011","unstructured":"Kokcu A. Relationship between endometriosis and cancer from current perspective. Arch Gynecol Obstet. 2011;284:1473\u20139.","journal-title":"Arch Gynecol Obstet"},{"key":"4_CR45","first-page":"933","volume":"5","author":"KA Rosenblatt","year":"1996","unstructured":"Rosenblatt KA, Thomas DB. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev. 1996;5:933\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 1","key":"4_CR46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000052878","volume":"50","author":"EJ Thomas","year":"2000","unstructured":"Thomas EJ, Campbell IG. Molecular genetic defects in endometriosis. Gynecol Obstet Invest. 2000;50 Suppl 1:44\u201350.","journal-title":"Gynecol Obstet Invest"},{"key":"4_CR47","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1158\/0008-5472.CAN-11-1562","volume":"71","author":"B Guan","year":"2011","unstructured":"Guan B, Wang TL, Shih IM. ARID1A, a factor that promotes formation of SWI\/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 2011;71:6718\u201327.","journal-title":"Cancer Res"},{"key":"4_CR48","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PAS.0b013e318212782a","volume":"35","author":"B Guan","year":"2011","unstructured":"Guan B, Mao TL, Panuganti PK, et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol. 2011;35:625\u201332.","journal-title":"Am J Surg Pathol"},{"key":"4_CR49","doi-asserted-by":"crossref","unstructured":"Jones S, Li M, Parsons DW, et al. Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat. 2011;33:100\u20133.","DOI":"10.1002\/humu.21633"},{"key":"4_CR50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0002-9378(99)70663-0","volume":"180","author":"BY Karlan","year":"1999","unstructured":"Karlan BY, Baldwin RL, Lopez-Luevanos E, et al. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening. Am J Obstet Gynecol. 1999;180:917\u201328.","journal-title":"Am J Obstet Gynecol"},{"key":"4_CR51","doi-asserted-by":"crossref","unstructured":"Collins IM, Domchek SM, Huntsman DG, et al. The tubal hypothesis of ovarian cancer: caution needed. Lancet Oncol;12:1089\u20131091.","DOI":"10.1016\/S1470-2045(11)70222-4"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","volume":"22","author":"PA Shaw","year":"2009","unstructured":"Shaw PA, Rouzbahman M, Pizer ES, et al. Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers. Mod Pathol. 2009;22:1133\u20138.","journal-title":"Mod Pathol"},{"key":"4_CR53","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2559.2001.1163c.x","volume":"38","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Verheijen RH, et al. Cell cycle-related proteins p21 and bcl-2: markers of differentiation in the human fallopian tube. Histopathology. 2001;38:481\u20132.","journal-title":"Histopathology"},{"key":"4_CR54","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(01)05992-X","volume":"358","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP, et al. Tubal ligation and risk of ovarian cancer. Lancet. 2001;358:844.","journal-title":"Lancet"},{"key":"4_CR55","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","volume":"90","author":"JM Piek","year":"2003","unstructured":"Piek JM, Verheijen RH, Kenemans P, et al. BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecol Oncol. 2003;90:491.","journal-title":"Gynecol Oncol"},{"key":"4_CR56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","volume":"80","author":"PJ Paley","year":"2001","unstructured":"Paley PJ, Swisher EM, Garcia RL, et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol. 2001;80:176\u201380.","journal-title":"Gynecol Oncol"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ygyno.2009.06.032","volume":"115","author":"AK Folkins","year":"2009","unstructured":"Folkins AK, Saleemuddin A, Garrett LA, et al. Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer. Gynecol Oncol. 2009;115:108\u201311.","journal-title":"Gynecol Oncol"},{"key":"4_CR58","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","volume":"19","author":"S Salvador","year":"2009","unstructured":"Salvador S, Gilks B, Kobel M, et al. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 2009;19:58\u201364.","journal-title":"Int J Gynecol Cancer"},{"key":"4_CR59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","volume":"53","author":"EA Jarboe","year":"2008","unstructured":"Jarboe EA, Folkins AK, Drapkin R, et al. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology. 2008;53:127\u201338.","journal-title":"Histopathology"},{"key":"4_CR60","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","volume":"73","author":"DA Bell","year":"1994","unstructured":"Bell DA, Scully RE. Early de novo ovarian carcinoma. A study of fourteen cases. Cancer. 1994;73:1859\u201364.","journal-title":"Cancer"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0046-8177(99)90269-1","volume":"30","author":"BA Werness","year":"1999","unstructured":"Werness BA, Afify AM, Bielat KL, et al. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum Pathol. 1999;30:151\u20137.","journal-title":"Hum Pathol"},{"key":"4_CR62","first-page":"263","volume":"106","author":"H Okamura","year":"2001","unstructured":"Okamura H, Katabuchi H. Detailed morphology of human ovarian surface epithelium focusing on its metaplastic and neoplastic capability. Ital J Anat Embryol. 2001;106:263\u201376.","journal-title":"Ital J Anat Embryol"},{"key":"4_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(04)42001-4","volume":"242","author":"H Okamura","year":"2005","unstructured":"Okamura H, Katabuchi H. Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis. Int Rev Cytol. 2005;242:1\u201354.","journal-title":"Int Rev Cytol"},{"key":"4_CR64","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T","volume":"89","author":"RR Barakat","year":"2000","unstructured":"Barakat RR, Federici MG, Saigo PE, et al. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer. 2000;89:383\u201390.","journal-title":"Cancer"},{"key":"4_CR65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ygyno.2007.03.028","volume":"106","author":"JD Seidman","year":"2007","unstructured":"Seidman JD, Wang BG. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Gynecol Oncol. 2007;106:201\u20136.","journal-title":"Gynecol Oncol"},{"key":"4_CR66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00004347-199904000-00009","volume":"18","author":"ME Sherman","year":"1999","unstructured":"Sherman ME, Lee JS, Burks RT, et al. Histopathologic features of ovaries at increased risk for carcinoma. A case\u2013control analysis. Int J Gynecol Pathol. 1999;18:151\u20137.","journal-title":"Int J Gynecol Pathol"},{"key":"4_CR67","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","volume":"91","author":"JF Stratton","year":"1999","unstructured":"Stratton JF, Buckley CH, Lowe D, et al. Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. J Natl Cancer Inst. 1999;91:626\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"4_CR68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/humrep\/den358","volume":"24","author":"G Chene","year":"2009","unstructured":"Chene G, Penault-Llorca F, Le Bouedec G, et al. Ovarian epithelial dysplasia after ovulation induction: time and dose effects. Hum Reprod. 2009;24:132\u20138.","journal-title":"Hum Reprod"},{"key":"4_CR69","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/1097-0142(19950915)76:6<1027::AID-CNCR2820760617>3.0.CO;2-6","volume":"76","author":"L Deligdisch","year":"1995","unstructured":"Deligdisch L, Einstein AJ, Guera D, et al. Ovarian dysplasia in epithelial inclusion cysts A morphometric approach using neural networks. Cancer. 1995;76:1027\u201334.","journal-title":"Cancer"},{"key":"4_CR70","doi-asserted-by":"crossref","unstructured":"Pothuri B, Leitao MM, Levine DA et al. Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS One;5:e10358.","DOI":"10.1371\/journal.pone.0010358"}],"container-title":["Current Obstetrics and Gynecology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13669-011-0004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13669-011-0004-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13669-011-0004-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T05:28:30Z","timestamp":1561181310000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13669-011-0004-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,7]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s13669-011-0004-1","relation":{},"ISSN":["2161-3303"],"issn-type":[{"value":"2161-3303","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,7]]}}}